# US 2024/0198022 A1 · Cpap therapy adaptation system to mitigate pulmonary hyperinflation and method of operation thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0198022 A1
- Document ID: US20240198022A1
- Status: Published application
- Kind: A1
- Application number: 18/534,866
- Filed: 2023-12-11
- Published: 2024-06-20
- Earliest claimed: 2022-12-16
- Assignees: Koninklijke Philips N.V.
- Applicants: Koninklijke Philips N.V.
- Inventors: KEES HENDRIKS; JOACHIM JOHANNES KAHLERT; JOYCE VAN ZANTEN; PEDRO MIGUEL FERREIRA DOS SANTOS DA FONSECA
- Web page: https://patentgrep.com/patent/US20240198022A1

## CPC

- A61M 16/022: {Control means therefor}
- A61B 5/1135: {by monitoring thoracic expansion}
- A61B 5/7282: {Event detection, e.g. detecting unique waveforms indicative of a medical condition (cough events A61B5/0823; seizures A61B5/4094; sleep apnoea A61B5/4818)}
- A61M 16/0003: {Accessories therefor, e.g. sensors, vibrators, negative pressure}
- A61M 16/0066: {Blowers or centrifugal pumps}
- A61M 16/026: {specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis}
- G16H 20/40: relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
- G16H 40/63: for local operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- A61B 5/02405: {Determining heart rate variability}
- A61B 5/085: Measuring impedance of respiratory organs or lung elasticity
- A61B 5/087: Measuring breath flow
- A61B 5/1116: {Determining posture transitions}
- A61B 5/4812: {Detecting sleep stages or cycles}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61M 2016/0036: {in the breathing tube and used in both inspiratory and expiratory phase}
- A61M 2205/3303: Using a biosensor
- A61M 2205/332: Force measuring means
- A61M 2205/3327: Measuring
- A61M 2205/3331: Pressure; Flow
- A61M 2205/505: Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
- A61M 2230/005: Parameter used as control input for the apparatus
- A61M 2230/04: Heartbeat characteristics, e.g. ECG, blood pressure modulation
- A61M 2230/06: Heartbeat rate only
- A61M 2230/10: Electroencephalographic signals
- A61M 2230/40: Respiratory characteristics
- A61M 2230/42: Rate
- A61M 2230/60: Muscle strain, i.e. measured on the user
- A61M 2230/62: Posture
- A61M 2230/63: Motion, e.g. physical activity
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A positive airway pressure therapy device, which may include one or more of at least one controller; a flow generator configured to provide therapeutic air assist; a plurality of sensors including at least one electrocardiogram (ECG) sensor, and at least one photoplethysmogram (PPG) sensor, the at least one PPG sensor may be configured to determine hyperinflation and the implication on variability in stroke volume and ejection fraction and form corresponding stroke volume (SV) and ejection fraction (EF) information, and the at least one ECG sensor configured to sense heart rate (HR) and heart rate variability (HRV) and form corresponding HR and HRV sensor information; the at least one controller may be configured to: control a flow generator to provide the therapeutic air assist to the user in accordance with initial pressure values determined in accordance with default setting values; and may determine whether a venous return flow (VRF) is less than a venous threshold.

## Claims

### Claim 1

A positive airway pressure therapy device, comprising:
at least one controller;
a plurality of sensors including at least one electrocardiogram sensor, at least one photoplethysmogram, and at least one flow sensor, the at least one flow sensor configured to determine inspiratory and expiratory flow and form corresponding inspiratory and expiratory flow information, and the at least one ECG sensor configured to sense physiological parameters of a user and form corresponding ECG sensor information;
the at least one controller configured to:
control a flow generator to provide therapeutic air assist to the user in accordance with an initial setting mode;
determine a rise time of expiration based upon the expiratory flow information;
compare the rise time of expiration to a threshold rise time of expiration value to determine whether the rise time of expiration is less than the threshold rise time of expiration value;
determine hyperinflation is critical when the at least one controller determines that the rise time of expiration is less than the threshold rise time of expiration value; and
control the flow generator to operate in accordance with a hyperinflation mode to reduce therapeutic air assist to the user when the at least one controller determines that the hyperinflation is critical.

### Claim 2 (depends on 1)

The PAP therapy device according to claim 1, wherein the at least one controller is further configured to control the flow generator to reduce at least one of Bi-flex, C-flex, and A-flex settings of the PAP therapy device by a threshold pressure value when in the hyperinflation mode.

### Claim 3 (depends on 1)

The PAP therapy device according to claim 1, wherein the at least one controller is further configured to control the flow generator to decrease duration of pressure support during inspiration cycle for N breath cycles by a threshold time value when in the hyperinflation mode, where N is an integer.

### Claim 4 (depends on 1)

The PAP therapy device according to claim 1, wherein the at least one controller is further configured to control the flow generator to decrease expiration pressure by a threshold pressure value when the PAP therapy device is in one of the hyperinflation mode and in a BiPAP therapy mode.

### Claim 5 (depends on 1)

The PAP therapy device according to claim 1, wherein the at least one controller is further configured to control the flow generator to reduce at least one of duration of pressure support during inspiration cycle and inspiration pressure by corresponding threshold amounts when in the hyperinflation mode.

### Claim 6 (depends on 1)

The PAP therapy device according to claim 1, wherein the plurality of sensors includes a chest sensor and an abdominal area sensor configured to measure a breathing pattern and extension of a chest of the user and form corresponding chest inflation sensor information.

### Claim 7 (depends on 6)

The PAP therapy device according to claim 6, wherein the at least one controller is further configured to compare the chest inflation sensor information to a threshold chest inflation value.

### Claim 8 (depends on 7)

The PAP therapy device according to claim 7, wherein when in the hyperinflation mode, the at least one controller is further configured to determine the hyperinflation is not critical when the CISI is determined to be less than the Tci.

### Claim 9 (depends on 8)

The PAP therapy device according to claim 8, wherein the at least one controller is further configured to control the flow generator to return to operation in accordance with the initial setting mode to restore therapeutic air assist to the user in accordance with the initial setting mode, when the at least one controller determines that the hyperinflation is not critical.

### Claim 10 (depends on 9)

The PAP therapy device according to claim 9, wherein the at least one controller is further configured to save in a memory current hyperinflation mode operating parameters of the flow generator prior to returning to operation in accordance with the initial setting mode from the hyperinflation mode.

### Claim 11 (depends on 10)

The PAP therapy device according to claim 10, wherein when the at least one controller determines that the hyperinflation is critical, the at least one controller is further configured to change operating parameters of the flow generator to the saved current hyperinflation mode operating parameters.

### Claim 12 (depends on 1)

The PAP therapy device according to claim 1, wherein the at least one controller is further configured to determine the hyperinflation is not critical when the at least one controller determines that the rise time of expiration is not less than the threshold rise time of expiration.

### Claim 13 (depends on 8)

The PAP therapy device according to claim 8, wherein the at least one controller is further configured to control the flow generator to return to operation in accordance with the initial setting mode to restore therapeutic air assist to the user in accordance with the initial setting mode, when the at least one controller determines that hyperinflation is not critical.

### Claim 14 (depends on 1)

The PAP therapy device according to claim 1, wherein the at least one controller is further configured to obtain PPG sensor information from the at least one PPG sensor and determine variability in stroke volume and ejection fraction and form corresponding stroke volume and ejection fraction information.

### Claim 15

A positive airway pressure therapy device, comprising:
at least one controller;
a flow generator configured to provide therapeutic air assist;
a plurality of sensors including at least one electrocardiogram sensor, and at least one photoplethysmogram sensor, the at least one PPG sensor configured to determine variability in stroke volume and ejection fraction and form corresponding stroke volume and ejection fraction information, and the at least one ECG sensor configured to sense heart rate and heart rate variability and form corresponding HR and HRV sensor information;
the at least one controller configured to:
control the flow generator to provide the therapeutic air assist to the user in accordance with initial pressure values determined in accordance with default setting values;
determine whether venous return flow is less than a venous threshold for venous return flow and whether stroke volume is less than a stroke threshold for stroke volume; and
decrease the initial pressure values by a default pressure value for N breath cycles, where N is an integer, when the at least one controller determines that the venous return flow is less than the threshold for venous return flow and the stroke volume is less than the threshold for stroke volume.
